Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preliminary Safety and Efficacy of Semaglutide and Naltrexone Combination Therapy for Alcohol Use Disorder

NCT07249554 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT07249554
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07249554 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preliminary Safety and Efficacy of Semaglutide and Naltrexone Combination Therapy for Alcohol Use Disorder
Lead sponsor
Johns Hopkins University
Phase
Phase 2
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
September 30, 2028
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder